drugset / Trial / NCT02910778

The Effect of Ticagrelor With or Without Atorvastatin on Endothelial Function in Healthy Males

NCT02910778 ↗

Phase 4 Completed 32 enrolled Medical University of Vienna
RandomizedParallel-groupTriple-blindTreatment

Summary

To test the effect of atorvastatin or placebo in combination with ticagrelor on ACh-induced vasodilatation of the forearm resistance vasculature as assessed by forearm blood flow (FBF) measurement before and 10 min after a 20 min forearm ischemia. The area under the dose-effect curve (AUC) of different ACh doses will be calculated and compared between treatment groups (atorvastatin + ticagrelor vs. placebo + ticagrelor) and different time points (pre-ischemia vs. post-ischemia).

Timeline

Start
2016-10
Primary completion
2017-02
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg —
Subject Ticagrelor Small molecule 180 mg Oral

Indications